Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate Cancer incidence and mortality rates. Eur Urol. 2020;77(1):38–52. https://doi.org/10.1016/j.eururo.2019.08.005.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  PubMed  Google Scholar 

Tsodikov A, Gulati R, Heijnsdijk EA, Pinsky PF, Moss SM, Qiu S, et al. Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO trials. Ann Intern Med. 2017;167(7):449–55.

Article  PubMed  PubMed Central  Google Scholar 

Donohoe KJ, Cohen EJ, Giammarile F, Grady E, Greenspan BS, Henkin RE, et al. Appropriate use criteria for bone scintigraphy in prostate and breast cancer: summary and excerpts. Soc Nuclear Med. 2017;

Mottet N, Van Den Bergh RCN, Briers E, Van Den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243–62. https://doi.org/10.1016/j.eururo.2020.09.042.

Article  CAS  PubMed  Google Scholar 

Trabulsi EJ, Rumble RB, Vargas HA. Optimum imaging strategies for advanced prostate Cancer: ASCO guideline summary. JCO oncology practice. 2020;16(4):170–6.

Article  PubMed  Google Scholar 

Schaeffer E, Srinivas S, Antonarakis ES, Armstrong AJ, Bekelman JE, Cheng H, et al. NCCN guidelines insights: prostate Cancer, version 1.2021: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2021;19(2):134–43.

Article  CAS  Google Scholar 

Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med. 2005;46(8):1356–67.

PubMed  Google Scholar 

Ghosh A, Heston WD. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem. 2004;91(3):528–39.

Article  CAS  PubMed  Google Scholar 

Zhao J, Mangarova DB, Brangsch J, Kader A, Hamm B, Brenner W, et al. Correlation between Intraprostatic PSMA Uptake and MRI PI-RADS of [68Ga]Ga-PSMA-11 PET/MRI in Patients with Prostate Cancer: Comparison of PI-RADS Version 2.0 and PI-RADS Version 2.1. Cancers. 2020;12(12):3523. Available from: https://www.mdpi.com/2072-6694/12/12/3523

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, et al. 68 Ga-PSMA PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2017;44(6):1014–24.

Article  PubMed  Google Scholar 

Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, et al. EANM procedure guidelines for radionuclide therapy with 177 Lu-labelled PSMA-ligands (177 Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2019;46(12):2536–44.

Article  PubMed  Google Scholar 

Hijazi S, Meller B, Leitsmann C, Strauss A, Meller J, Ritter C, et al. Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography. Prostate. 2015;75(16):1934–40.

Article  CAS  PubMed  Google Scholar 

Habl G, Sauter K, Schiller K, Dewes S, Maurer T, Eiber M, et al. 68Ga-PSMA-PET for radiation treatment planning in prostate cancer recurrences after surgery: individualized medicine or new standard in salvage treatment. Prostate. 2017;77(8):920–7.

Article  CAS  PubMed  Google Scholar 

Maurer T, Gschwend JE, Rauscher I, Souvatzoglou M, Haller B, Weirich G, et al. Diagnostic efficacy of 68gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer. J Urol. 2016;195(5):1436–43.

Article  PubMed  Google Scholar 

PET Scanners per 1 million - IAEA Medical Imaging and Nuclear Medicine Global Resources Database (IMAGINE) [Internet]. International Atomic Energy Agency (IAEA). 2023. Available from: https://www.iaea.org/resources/hhc/nuclear-medicine/databases/imagine/pet-scanners.

Organization WH. Global atlas of medical devices 2022. Available from: https://apps.who.int/iris/bitstream/handle/10665/364709/9789240062207-eng.pdf?sequence=1.

Google Scholar 

Health N. Cost of PET Scan in Lagos: Nimed Health; 2021 [Available from: https://nimedhealth.com.ng/2021/09/17/cost-of-pet-scan-in-lagos-nigeria/.

Infoline A. PET CT Scan Cost in African Cities: Africa Infoline; 2024 [Available from: https://africainfoline.com/listing/scans/africa/pet-ct-scan-cost-in-african-cities-find-best-hospital-and-book-appointment/.

Albalooshi B. Direct comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer. Asia Oceania Journal of Nuclear Medicine and Biology. 2020;8(1):1.

PubMed  PubMed Central  Google Scholar 

Rahmim A, Zaidi H. PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun. 2008;29(3):193–207. https://doi.org/10.1097/MNM.0b013e3282f3a515.

Article  PubMed  Google Scholar 

Fallahi B, Khademi N, Karamzade-Ziarati N, Fard-Esfahani A, Emami-Ardekani A, Farzanefar S, et al. 99mTc-PSMA SPECT/CT versus 68Ga-PSMA PET/CT in the evaluation of metastatic prostate cancer. Clin Nucl Med. 2021;46(2):e68–74.

Article  PubMed  Google Scholar 

Su H-C, Zhu Y, Ling G-W, Hu S-L, Xu X-P, Dai B, et al. Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse. Asian journal of andrology. 2017;19(3):267–71. https://doi.org/10.4103/1008-682X.192638. Available from: https://pubmed.ncbi.nlm.nih.gov/27976632, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427779/

Article  CAS  PubMed  Google Scholar 

Robu S, Schottelius M, Eiber M, Maurer T, Gschwend J, Schwaiger M, et al. Preclinical Evaluation and First Patient Application of ^99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer. J Nucl Med. 2017;58(2):235–42. https://doi.org/10.2967/jnumed.116.178939. Available from: https://jnm.snmjournals.org/content/jnumed/58/2/235.full.pdf

Article  CAS  PubMed  Google Scholar 

Werner P, Neumann C, Eiber M, Wester HJ, Schottelius M. [99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center. EJNMMI Res. 2020;10(1):45. https://doi.org/10.1186/s13550-020-00635-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schmidkonz C, Goetz TI, Kuwert T, Ritt P, Prante O, Bäuerle T, et al. PSMA SPECT/CT with 99mTc-MIP-1404 in biochemical recurrence of prostate cancer: predictive factors and efficacy for the detection of PSMA-positive lesions at low and very-low PSA levels. Ann Nucl Med. 2019;33(12):891–8. https://doi.org/10.1007/s12149-019-01400-6.

Article  CAS  PubMed  Google Scholar 

Kabunda J, Gabela L, Kalinda C, Aldous C, Pillay V, Nyakale N. Comparing 99mTc-PSMA to 99mTc-MDP in prostate Cancer staging of the skeletal system. Clin Nucl Med. 2021;46(7):562.

Article  PubMed  PubMed Central  Google Scholar 

Rathke H, Afshar-Oromieh A, Giesel FL, Kremer C, Flechsig P, Haufe S, et al. Intra-individual comparison of Tc-99m-MDP bone scan and the PSMA-ligand Tc-99m-MIP-1427 in patients with osseous metastasized prostate cancer. J Nucl Med. 2018;

Lawal IO, Ankrah AO, Mokgoro NP, Vorster M, Maes A, Sathekge MM. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: a comparative analysis with Ga-68 PSMA PET/CT. Prostate. 2017;77(11):1205–12. https://doi.org/10.1002/pros.23379?download=true.

Article  CAS  PubMed  Google Scholar 

Vangu M, Kasapato T. Imaging with PSMA: which approach when only tech rather than Galli is available? J Nucl Med. 2019;60(supplement 1):1559. https://jnm.snmjournals.org/content/60/supplement_1/1559.short

Google Scholar 

Ellmann A. A44 nuclear medicine in Africa. Nucl Med Commun. 2004;25(10):1066–7. https://journals.lww.com/nuclearmedicinecomm/Fulltext/2004/10000/A44_Nuclear_medicine_in_Africa.53.aspx

Article  Google Scholar 

Orunmuyi AT, Lawal IO, Omofuma OO, Taiwo OJ, Sathekge MM. Underutilisation of nuclear medicine scans at a regional hospital in Nigeria: need for implementation research. Ecancermedicalscience. 2020;14:1093. https://doi.org/10.3332/ecancer.2020.1093. https://pubmed.ncbi.nlm.nih.gov/33014135, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498276/

Article  PubMed  PubMed Central  Google Scholar 

Dondi M, Kashyap R, Paez D, Pascual T, Zaknun J, Bastos FM, et al. Trends in nuclear medicine in developing countries. J Nucl Med. 2011;52(Supplement 2):16S–23S. https://doi.org/10.2967/jnumed.111.089193. Available from: https://jnm.snmjournals.org/content/jnumed/52/Supplement_2/16S.full.pdf

Article  PubMed  Google Scholar 

Lee DS, Lee Y-S, Lee JS, Suh MS. Promotion of nuclear medicine-related sciences in developing countries. Nucl Med Mol Imaging. 2019;53(2):73–82. https://doi.org/10.1007/s13139-019-00583-0. Available from: https://pubmed.ncbi.nlm.nih.gov/31057676, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473009/

Article  PubMed  PubMed Central  Google Scholar 

Jaiyeola AO, Bayat A. Assessment of trends in income poverty in Nigeria from 2010–2013: an analysis based on the Nigeria general household survey. J Poverty. 2020;24(3):185–202.

Article  Google Scholar 

Tabata K-i, Niibe Y, Satoh T, Tsumura H, Ikeda M, Minamida S, et al. Radiotherapy for oligometastases and oligo-recurrence of bone in prostate cancer. Pulmonary medicine. 2012;2012

Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR. Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Front Oncol. 2013;2:215.

Article  PubMed  PubMed Central  Google Scholar 

Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. AJCC cancer staging manual. Springer; 2017.

Google Scholar 

Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. John Wiley & Sons; 2017.

Google Scholar 

Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37–46.

Article  Google Scholar 

Seifert R, Gafita A, Telli T, Voter A, Herrmann K, Pomper M, et al. Standardized PSMA-PET imaging of advanced prostate Cancer. Semin Nucl Med. 2024;54(1):60–8. https://doi.org/10.1053/j.semnuclmed.2023.07.005. https://www.sciencedirect.com/science/article/pii/S0001299823000594

Article  CAS  PubMed